XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.200
0.00 (0.00%)
Sep 8, 2026, 11:33 AM EDT - Market open

XBiotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6773120122107338
Market Cap Growth
-26.21%-39.48%-1.10%13.95%-68.42%-26.11%
Enterprise Value
-42-75-53-80-11399
Last Close Price
2.202.393.954.003.5111.13

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-87.6387.6387.6387.6387.63
PS Ratio
----26.6418.39
PB Ratio
0.520.520.660.560.441.26
P/TBV Ratio
0.520.520.660.560.441.26
P/FCF Ratio
-----5.13
P/OCF Ratio
-----4.87

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-----5.41
EV/FCF Ratio
-----1.51

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
--0.06---
Net Debt / Equity Ratio
-0.85-0.89-0.89-0.91-0.90-0.88
Net Debt / EBITDA Ratio
2.342.333.995.596.8210.56
Net Debt / FCF Ratio
2.683.125.0310.4814.11-3.59
Asset Turnover
----0.020.06
Quick Ratio
32.7515.8811.4932.9453.9271.22
Current Ratio
33.1516.0111.5633.0754.0771.49
Return on Equity (ROE)
-29.94%-28.23%-19.21%-10.69%-12.91%-5.63%
Return on Assets (ROA)
-19.30%-19.93%-12.47%-9.92%-8.27%-4.98%
Return on Invested Capital (ROIC)
-250.55%-321.51%-219.69%-179.70%-124.68%-34.91%
Return on Capital Employed (ROCE)
-37.00%-39.20%-23.10%-17.00%-14.20%-9.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-67.29%-62.50%-32.00%-20.17%-30.79%-5.15%
FCF Yield
-60.89%-55.18%-26.80%-15.68%-14.42%19.48%
Buyback Yield / Dilution
-0.04%-0.09%-0.07%0.00%-1.32%2.53%
SEC Filings: 10-K · 10-Q